Man Group’s GoodRx Holdings GDRX Stock Holding History

Man Group’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-80,666	Closed	-$219K	–	2463
2025 Q4	$219K	Buy	+80,666	New	+$265K	﹤0.01%	2104
2025 Q3	–	Sell	-14,515	Closed	-$72.3K	–	2307
2025 Q2	$72.3K	Sell	14,515 -23,768	-62%	-$103K	﹤0.01%	2133
2025 Q1	$169K	Buy	+38,283	New	+$180K	﹤0.01%	2057
2024 Q2	–	Sell	-46,433	Closed	-$330K	–	2101
2024 Q1	$330K	Buy	+46,433	New	+$307K	﹤0.01%	1912
2023 Q3	–	Sell	-209,717	Closed	-$1.4M	–	1713
2023 Q2	$1.16M	Buy	+209,717	New	+$1.13M	﹤0.01%	1348
2023 Q1	–	Sell	-355,395	Closed	-$1.98M	–	1131
2022 Q4	$1.66M	Buy	355,395 +188,295	+113%	+$928K	0.01%	1166
2022 Q3	$780K	Buy	+167,100	New	+$1.05M	﹤0.01%	1381
2022 Q2	–	Sell	-129,309	Closed	-$1.44M	–	1808
2022 Q1	$2.5M	Buy	129,309 +108,123	+510%	+$2.48M	0.01%	1151
2021 Q4	$692K	Buy	+21,186	New	+$852K	﹤0.01%	1440

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Man Group's GDRX Position: Q1 2026 in Review

Man Group sold out of GoodRx Holdings (GDRX) in Q1 2026, closing a stake of 80,666 shares — an estimated $219K sold.

Man Group first reported a position in GDRX in Q4 2021 and held it in 9 quarters. The position peaked at $2.5M in Q1 2022. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

Man Group reported no remaining GoodRx Holdings position as of Q1 2026 after selling out during the quarter.
Man Group sold 80,666 GoodRx Holdings shares in Q1 2026, an estimated $219K.
Man Group first reported a position in GoodRx Holdings in Q4 2021 and held it in 9 quarters.
Man Group's GoodRx Holdings position peaked at $2.5M in Q1 2022.
174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.